Unexplained extreme hyperbilirubinemia among neonates in a multihospital healthcare system

Blood Cells, Molecules, and Diseases

Volumn 50, Issue 2, 2013, Pages 105-109

  Christensen, Robert D ^a,b   Lambert, Diane K ^b   Henry, Erick ^a,c   Eggert, Larry D ^a,d   Yaish, Hassan M ^e   Reading, N Scott ^f   Prchal, Josef T ^e,f  

^a Women and Newborns Clinical Program   (United States)

^b McKay Dee Hospital Center   (United States)

^c Institute for Healthcare Delivery Research   (United States)

^d Dixie Regional Medical Center   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f ARUP LABORATORIES   (United States)

Author keywords

Bilirubin; Hemolysis; Hyperbilirubinemia; Jaundice; Newborn

Indexed keywords

BILIRUBIN; HAPTOGLOBIN; HEMOGLOBIN; IMMUNOGLOBULIN ANTIBODY; PYRUVATE KINASE;

ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD EXAMINATION; BLOOD GROUP TYPING; CHILDBIRTH; CONTROLLED STUDY; COOMBS TEST; ELECTROPHORESIS; ERYTHROCYTE STRUCTURE; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH CARE SYSTEM; HEINZ BODY; HEMOLYSIS; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIHOSPITAL SYSTEM; NEWBORN; NEWBORN JAUNDICE; PRIORITY JOURNAL;

ADULT; BLOOD GROUPING AND CROSSMATCHING; BLOOD PROTEIN ELECTROPHORESIS; CAUSALITY; COOMBS TEST; DIAGNOSTIC TESTS, ROUTINE; DISEASE OUTBREAKS; ETHNIC GROUPS; FEMALE; GESTATIONAL AGE; HAPTOGLOBINS; HEMOLYSIS; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INCIDENCE; INFANT, NEWBORN; KERNICTERUS; LENGTH OF STAY; MALE; MULTI-INSTITUTIONAL SYSTEMS; NEONATAL SCREENING; PREGNANCY; PYRUVATE KINASE; RETROSPECTIVE STUDIES; UTAH;

EID: 84871960448     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2012.10.004     Document Type: Article

References (40)

1. Kaplan M., Hammerman C., Vreman R.A., Stevenson D.K., Beutler E. Acute hemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes. J. Pediatr. 2001, 139:137-140.
2. Kaplan M., Muraca M., Hammerman C., Rubaltelli F.F., Vilei M.T., Vreman H.J., Stevenson D.K. Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice. Pediatrics 2002, 110:e47-e49.
3. Maisels M.J., Kring E. The contribution of hemolysis to early jaundice in normal newborns. Pediatrics 2005, 118:276-279.
4. Cohen R.S., Wong R.J., Stevenson D.K. Understanding neonatal jaundice: a perspective on causation. Pediatr. Neonatol. 2010, 51:143-148.
5. Stevenson D.K., Vreman H.J., Wong R.J. Bilirubin production and the risk of bilirubin neurotoxicity. Semin. Perinatol. 2011, 35:121-126.
6. Bhutani V.K., Johnson L.H., Maisels M.J., Newman T.B., Phibbs C., Stark A.R., Yeargin-Allsopp M. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J. Perinatol. 2004, 24:650-662.
7. Johnson L., Bhutani V.K., Karp K., Sivieri E.M., Shapiro S.M. Clinical report from the pilot USA kernicterus registry (1992 to 2004). J. Perinatol. 2009, 29:S25-S45.
8. Bhutani V.K., Johnson L. Synopsis report from the pilot USA kernicterus registry. J. Perinatol. 2009, 29:S4-S7.
9. Newman T.B., Liljestrand P., Escobar G.J. Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization. Pediatrics 2003, 111:1303-1311.
10. Christensen R.D., Eggert L.D., Baer V.L., Smith K.N. Pyruvate kinase deficiency as a cause of extreme hyperbilirubinemia in neonates from a polygamist community. J. Perinatol. 2010, 30:233-236.
11. Christensen R.D., Yaish H.M., Johnson C.B., Bianchi P., Zanella A. Six children with pyruvate kinase deficiency from one small town: molecular characterization of the PK-LR gene. J. Pediatr. 2011, 159:695-697.
12. Kaplan M., Renbaum P., Levy-Lahad E., Hammerman C., Lahad A., Beutler E. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:12128-12132.
13. Lee-Potter J.P., Deacon-Smith R.A., Simpkiss M.J., Kamuzora H., Lehmann H. A new cause of haemolytic anaemia in the newborn. A description of an unstable fetal haemoglobin: F Poole, alpha2-G-gamma2 130 trptophan yields glycine. J. Clin. Pathol. 1975, 28:317-320.
14. Mah M.P., Clark S.L., Akhigbe E., Englebright J., Frye D.K., Meyers J.A., Perlin J.B., Rodriguez M., Shepard A. Reduction of severe hyperbilirubinemia after institution of predischarge bilirubin screening. Pediatrics 2011, 125:e1143-e1148.
15. Eggert L.D., Wiedmeier S.E., Wilson J., Christensen R.D. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics 2006, 117:e855-e858.
16. Flaherman V.J., Kuzniewicz M.W., Escobar G.J., Newman T.B. Total serum bilirubin exceeding exchange transfusion thresholds in the setting of universal screening. J. Pediatr. 2012, 160:796-800.
17. Watchko J.F., Lin Z., Clark R.H., Kelleher A.S., Walker W.W., Spitzer A.R. Complex multifactorial nature of significant hyperbilirubinemia in neonates. Pediatrics 2009, 124:e868-e877.
18. Watchko J.F., Lin Z. Exploring the genetic architecture of neonatal hyperbilirubinemia. Semin. Fetal Neonatal Med. 2010, 15:169-175.
19. Chavez-Bueno S., Beasley S.A., Goldbeck J.M., Bright B.C., Morton D.J., Whitby P.W., Stull T.L. Haptoglobin concentrations in preterm and term newborns. J. Perinatol. 2011, 31:500-503.
20. Newman T.B., Liljestrand P., Jeremy R.J., Ferriero M.M., Wu Y.W., Hudes E.S. Outcomes among newborns with total serum biliribin levels of 25 mg per deciliter or more. N. Eng. J. Med. 2006, 354:1889-1900.
21. Wennberg R.P., Ahlfors C.E., Bhutani V.K., Johnson L.H., Shapiro S.M. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006, 117:474-485.
22. Lin A., Fontaine J., Watchko J.F. Coexpression of gene polymorphisms involved in bilirubin production and metabolism. Pediatrics 2008, 122:e156-e158.
23. Berardi A., Lugli L., Ferrari F., Gargano G., D'Apolito M., Marrone A., Iolascon A. Kernicterus associated with hereditary spherocytosis and UGT1A1 promoter polymorphism. Biol. Neonate 2006, 90:243-246.
24. del Giudice E.M., Perrotta S., Nobili B., Specchia C., d'Urzo G., Iolascon A. Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis. Blood 1999, 94:2259-2262.
25. Kaplan M., Renbaum P., Vreman H.J., Wong R.J., Levy-Lahad E., Hammerman C., Stevenson D.K. (TA)n UGT 1A1 promoter polymorphism: a crucial factor in the pathophysiology of jaundice in G-6-PD deficient neonates. Pediatr. Res. 2007, 61:727-731.
26. Prchal J.T., Castleberry R.P., Parmley R.T., Crist W.M., Malluh A. Hereditary pyropoikilocytosis and elliptocytosis: clinical, laboratory, and ultrastructural features in infants and children. Pediatr. Res. 1982, 16:484-489.
27. Coetzer T., Palek J., Lawler J., Liu S.C., Jarolim P., Lahav M., Prchal J.T., Wang W., Alter B.P., Schewitz G. Structural and functional heterogeneity of alpha spectrin mutations involving the spectrin heterodimer self-association site: relationships to hematologic expression of homozygous hereditary elliptocytosis and hereditary pyropoikilocytosis. Blood 1990, 75:2235-2244.
28. Christensen R.D., Henry E. Hereditary spherocytosis in neonates with hyperbilirubinemia. Pediatrics 2010, 125:120-125.
29. Sheffield M.J., Christensen R.D. Evaluating neonatal hyperbilirubinemia in late preterm Hispanic twins led to the diagnosis of hereditary spherocytosis in them, and in their sibling and in their mother. J. Perinatol. 2011, 31:625-627.
30. Alfrey C.P., Rice L., Udden M.M., Driscoll T.B. Neocytolysis: physiological down-regulator of red-cell mass. Lancet 1997, 349:1389-1390.
31. Rice L., Alfrey C.P. Modulation of red cell mass by neocytolysis in space and on Earth. Pflugers Arch. 2000, 441:R91-R94.
32. Risso A., Turello M., Biffoni F., Antonutto G. Red blood cell senescence and neocytolysis in humans after high altitude acclimatization. Blood Cells Mol. Dis. 2007, 38:83-92.
33. Korell J., Coulter C.V., Duffull S.B. A statistical model for red blood cell survival. J. Theor. Biol. 2011, 268:39-49.
34. Agarwal N., Prchal J.T. Erythropoietic agents and the elderly. Semin. Hematol. 2008, 45:267-275.
35. Yoon D., Ponka P., Prchal J.T. Hypoxia and hematopoiesis. Am. J. Physiol. Cell Physiol. 2011, 300:C1215-C1222.
36. Bender J.W., Reilly M.P., Asakura T. Molecular stability and function of hemoglobins Hasharon (alpha(2)47 (CD5)Asp-His beta 2) and Hasharon (alpha(2)47 (CD5)Asp-His delta 2). Hemoglobin 1984, 8:61-73.
37. Crowley M.A., Mollan T.L., Abdulmalik O.Y., Butler A.D., Goodwin E.F., Sarkar A., Stolle C.A., Gow A.J., Olson J.S., Weiss M.J. A hemoglobin variant associated with neonatal cyanosis and anemia. N. Engl. J. Med. 2011, 364:1837-1843.
38. Luo W., Hu H., Chang R., Zhong J., Knabel M., O'Meally R., Cole R.N., Pandey A., Semenza G.L. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 2011, 145:732-744.
39. Prchal J.T., Gregg X.T. Red cell enzymes. Hematology Am. Soc. Hematol. Educ. Program 2005, 19-23.
40. Coetzer T.L., Sahr K., Prchal J.T., Blacklock H., Peterson L., Koler R., Doyle J., Manaster J., Palek J. Four different mutations in codon 28 of alpha spectrin are associated with structurally and functionally abnormal spectrin alpha I/74 in hereditary elliptocytosis. J. Clin. Invest. 1991, 88:743-749.